Ubs Group Ag Virax Biolabs Group LTD Transaction History

Ubs Group Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$0.31 - $0.41 $45 - $60	147 New	147 $0
Q1 2023 May 12, 2023	SELL	$0.64 - $1.21 $1,992 - $3,767	-3,114 Reduced 50.35%	3,071 $2,000
Q4 2022 Feb 08, 2023	SELL	$0.57 - $28.6 $3,426 - $171,914	-6,011 Reduced 49.29%	6,185 $4,000
Q3 2022 Nov 10, 2022	BUY	$2.47 - $32.9 $30,124 - $401,248	12,196 New	12,196 $38,000

Ticker VRAX
Exchange
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,374,100
Market Cap $22.4M
Description
Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid te...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.